AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2003
Nov 4, 2003
34519_dirs_2003-11-04_37b04ffc-fb13-4116-9624-9906d7c3f507.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2003-10-31
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2003-10-31 | Common Stock, par value $0.10 per share | P | 500 | $3.01 | Acquired | 345460 | Direct |
| 2003-11-03 | Common Stock, par value $0.10 per share | P | 300 | $3.06 | Acquired | 345760 | Direct |
| 2003-11-04 | Common Stock, par value $0.10 per share | P | 500 | $3.02 | Acquired | 346260 | Direct |
| 2003-11-04 | Common Stock, par value $0.10 per share | P | 500 | $3.01 | Acquired | 346760 | Direct |
Footnotes
F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
Jun 10
Report Publication Announcement
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25